Busuioc, C.; Ciocan-Cartita, C.A.; Braicu, C.; Zanoaga, O.; Raduly, L.; Trif, M.; Muresan, M.-S.; Ionescu, C.; Stefan, C.; Crivii, C.;
et al. Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma. J. Pers. Med. 2021, 11, 476.
https://doi.org/10.3390/jpm11060476
AMA Style
Busuioc C, Ciocan-Cartita CA, Braicu C, Zanoaga O, Raduly L, Trif M, Muresan M-S, Ionescu C, Stefan C, Crivii C,
et al. Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma. Journal of Personalized Medicine. 2021; 11(6):476.
https://doi.org/10.3390/jpm11060476
Chicago/Turabian Style
Busuioc, Constantin, Cristina Alexandra Ciocan-Cartita, Cornelia Braicu, Oana Zanoaga, Lajos Raduly, Monica Trif, Mihai-Stefan Muresan, Calin Ionescu, Cristina Stefan, Carmen Crivii,
and et al. 2021. "Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma" Journal of Personalized Medicine 11, no. 6: 476.
https://doi.org/10.3390/jpm11060476
APA Style
Busuioc, C., Ciocan-Cartita, C. A., Braicu, C., Zanoaga, O., Raduly, L., Trif, M., Muresan, M.-S., Ionescu, C., Stefan, C., Crivii, C., Al Hajjar, N., Mǎrgǎrit, S., & Berindan-Neagoe, I.
(2021). Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma. Journal of Personalized Medicine, 11(6), 476.
https://doi.org/10.3390/jpm11060476
